Abstract submission for AAIC 2024 opens in December 2023.

Developing Topic submissions are designed to bring the latest research findings in the field to AAIC attendees. Specifically, they are abstracts in which the research findings were not available by the general abstract submission deadline.

Note: Developing Topics abstracts will be considered for poster presentation only unless the research is considered to be late-breaking.

Criteria:

• Quality of scientific research.
• Relevance to Alzheimer’s disease and related disorders.
• Newness of information — abstracts related to COVID-19 are encouraged.
• Potential impact on the research community.
• Topics of interest include basic and translational science, diagnosis and prognosis, therapeutics and public health and psychosocial issues.

Additional Information:

• Previously submitted/reviewed abstracts will not be considered.
• A limited number of abstracts are selected, with selection based on timeliness and scientific merit.
• For studies of exceptional interest where multiple outcomes are to be presented, an extremely limited number of dedicated sessions are available. Consideration can be requested as part of the abstract submission process.
• Only under extraordinary circumstances will abstracts without results be considered.
• Accepted abstracts are published in an online supplement to the Association's journal, Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
• Developing Topics abstracts must be submitted via the online system.
• Developing Topics abstracts are not accepted for the Alzheimer's Imaging Consortium or Technology and Dementia.
• An author may present in two oral platforms as long as one is a Developing Topic session.